2. Patients with suspected pancreatic cancer based on morphological findings on standard imaging
3. CT or MRI or \[18F\]FDG PET/CT evaluated on MDT with no initial sign of distant metastases
4. Subjects must have been considered suitable for curative surgery at the time of the referral
5. Subjects must be able to read and understand the patient information in Danish to give informed consent
1. Male or female over 18 years old
2. Histological verified carcinoma from the lower esophagus, GEJ, or stomach
3. Subjects must be considered operable and resectable at the time of referral for MDT
4. Subjects must be able to read and understand the patient information in Danish to give informed consent
1. Male or female over 18 years old
2. Histological verified SRCC or PCC from the lower esophagus, GEJ, or stomach
3. Subjects with localized disease assigned to perioperative chemotherapy or subjects with metastatic disease assigned to palliative systemic treatment.
4. Subjects must be able to read and understand the patient information in Danish to give informed consent
You may not be if
1. Pregnancy or lactation
2. Weight more than the maximum limit of a PET/CT-scanner bed (140 kg)
3. History of allergic reaction due to compounds similar to the chemical composition of \[68Ga\]Ga-FAPI-46
Clareo Health | BEFAST Study, [68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer
